• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE TAG CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE TAG CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGMR404020J
Device Problem Unintended Movement (3026)
Patient Problem Vascular Dissection (3160)
Event Date 04/19/2021
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device remains implanted and is not available for investigation.Further information was requested but was not available.According to the gore® tag® conformable thoracic stent graft with active control system instructions for use (ifu), complications associated with the use of the gore® tag® thoracic endoprosthesis may include but are not limited to dissection, perforation, or rupture of the aortic vessel & surrounding vasculature, endoprosthesis migration and reoperation.
 
Event Description
On (b)(6) 2020, the patient underwent endovascular treatment of a type b aortic dissection using a gore® tag® conformable thoracic stent graft with active control system.On (b)(6) 2021, a distal migration (distance unknown) and ulcer-like projection (ulp) forming were observed.On (b)(6) 2021, a reintervention placing additional gore® tag® conformable thoracic stent grafts with active control system was performed.The patient tolerated the procedure.It is unknown what caused the device migration.Also, the cause of the ulcer-like projection (ulp) forming is unknown.Further information was requested but was not available.
 
Event Description
On (b)(6), 2020, the patient underwent endovascular treatment of a type b aortic dissection using a gore® tag® conformable thoracic stent graft with active control system.On (b)(6), 2021, a distal migration (distance unknown) and a distal stent graft-induced new entry(dsine) were observed.On (b)(6), 2021, a reintervention placing additional gore® tag® conformable thoracic stent grafts with active control system was performed.The patient tolerated the procedure.It was reported that the device migrated since some space was created due to the dissociation.
 
Manufacturer Narrative
Additional information: b5: event description.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE TAG CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key11780757
MDR Text Key264414157
Report Number2017233-2021-01955
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 05/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/05/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/13/2023
Device Catalogue NumberTGMR404020J
Was Device Available for Evaluation? No
Date Manufacturer Received05/05/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age76 YR
-
-